Wedbush Cuts Healthpeak Properties (NYSE:DOC) Price Target to $24.00

Healthpeak Properties (NYSE:DOC) had its price objective cut by analysts at Wedbush from $27.00 to $24.00 in a research note issued on Friday,Benzinga reports. The firm currently has an “outperform” rating on the real estate investment trust’s stock. Wedbush’s target price would suggest a potential upside of 22.62% from the stock’s current price. Wedbush also issued estimates for Healthpeak Properties’ FY2025 earnings at $1.85 EPS and FY2026 earnings at $1.96 EPS.

A number of other research analysts also recently issued reports on the stock. Morgan Stanley upgraded shares of Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 target price for the company in a research report on Wednesday, January 15th. Mizuho decreased their target price on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research report on Thursday, December 5th. Deutsche Bank Aktiengesellschaft upgraded shares of Healthpeak Properties from a “hold” rating to a “buy” rating and boosted their target price for the company from $20.00 to $28.00 in a research report on Monday, October 21st. StockNews.com downgraded shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a research report on Wednesday, October 30th. Finally, Wells Fargo & Company decreased their target price on shares of Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a research report on Tuesday, December 10th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Healthpeak Properties currently has an average rating of “Moderate Buy” and a consensus target price of $24.00.

Healthpeak Properties Trading Down 1.9 %

NYSE:DOC opened at $19.57 on Friday. Healthpeak Properties has a 12 month low of $16.01 and a 12 month high of $23.26. The firm has a fifty day simple moving average of $20.36 and a 200-day simple moving average of $21.46. The company has a current ratio of 1.35, a quick ratio of 1.31 and a debt-to-equity ratio of 0.96. The company has a market capitalization of $13.69 billion, a P/E ratio of 55.92, a PEG ratio of 2.18 and a beta of 1.15.

Institutional Trading of Healthpeak Properties

Institutional investors and hedge funds have recently modified their holdings of the stock. JPMorgan Chase & Co. increased its stake in shares of Healthpeak Properties by 23.2% during the third quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock worth $493,115,000 after purchasing an additional 4,056,931 shares in the last quarter. Thrivent Financial for Lutherans acquired a new position in Healthpeak Properties during the third quarter worth about $1,880,000. Swedbank AB acquired a new position in Healthpeak Properties during the third quarter worth about $1,832,000. Pathstone Holdings LLC acquired a new position in Healthpeak Properties during the third quarter worth about $1,968,000. Finally, Associated Banc Corp acquired a new position in Healthpeak Properties during the third quarter worth about $10,559,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.